Alzheimer's drug trial failures may be due to second disease

Ryan Maass
LEXINGTON, Ky., Oct. 3 (UPI) — The failure of many Alzheimer’s disease drug trials can be traced back to patients having a second dementia-causing ailment, Kentucky University scientists say. …read more

Source:: National and World Stories


You must be logged in to post a comment Login